Korean J Hepatobiliary Pancreat Surg.  2012 May;16(2):55-58. 10.14701/kjhbps.2012.16.2.55.

Hepatic resection margin predicts survival in colorectal cancer with hepatic metastasis

  • 1Department of Surgery, Kosin University College of Medicine, Busan, Korea. yoonmhj@dreamwiz.com


Prognostic factors for colorectal cancer with hepatic metastasis are not well-established. We investigated the factors that predicted survival following surgical resection of hepatic metastases in patients with colorectal cancer.
Fifty-three patients underwent resection of hepatic metastases of colorectal cancer between January 2000 and December 2005, with follow-up periods that ranged from 3 to 119 months. In this retrospective study, the effects of sex, age, type of hepatic resection, T stage and N stage of the primary cancer, number and size of metastatic hepatic tumors, synchronicity or metachronicity of the liver metastases, surgical resection margins, and preoperative carcinoembryonic antigen (CEA) levels on 1-year and 3-year survival were analyzed using the Kaplan-Meier method and the log rank test.
Median survival was 39.9 months and the 3-year survival rate was 62.2%. Twenty patients died during the follow-up period of 3 to 119 months (mean, 48.8+/-34.24). In univariate analysis, only the surgical margin of the hepatic metastasis resection correlated significantly with 3-year survival. Sex, age, T stage and N stage of the primary cancer, synchronicity or metachronicity of the metastases, number and size of hepatic metastases, type of hepatic resection and preoperative CEA levels did not predict long-term outcome.
Hepatic resection provides a safe and effective treatment in patients with hepatic metastasis from colorectal cancer. In this study, only the surgical resection margin of the hepatic metastasis of colorectal cancer significantly predicted survival.


Colorectal cancer; Hepatic metastasis; Prognostic factor

MeSH Terms

Carcinoembryonic Antigen
Colorectal Neoplasms
Follow-Up Studies
Neoplasm Metastasis
Retrospective Studies
Survival Rate
Carcinoembryonic Antigen


1. Benson AB 3rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm. 2007. 13:6 Suppl C. S5–S18.
2. Taylor I. Liver metastases from colorectal cancer: lessons from past and present clinical studies. Br J Surg. 1996. 83:456–460.
3. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990. 77:1241–1246.
4. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002. 235:759–766.
5. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995. 19:59–71.
6. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999. 230:309–318.
7. Nordlinger B, Guiguet M, Vaillant JC, et al. Association Franaise de Chirurgie. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 1996. 77:1254–1262.
8. Leveson SH, Wiggins PA, Giles GR, et al. Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg. 1985. 72:128–130.
9. Gilbert HA, Kagan AR. Weiss L, editor. Metastases: incidence, detection, and evaluation without histologic confirmation. Fundamental aspects of metastases. 1976. Amsterdam: North Holland Publishing Co;385–405.
10. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984. 199:502–508.
11. Scheele J, Rudroff C, Altendorf-Hofmann A. Resection of colorectal liver metastases revisited. J Gastrointest Surg. 1997. 1:408–422.
12. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994. 116:703–710.
13. Adson MA. Resection of liver metastases--when is it worthwhile? World J Surg. 1987. 11:511–520.
14. Holm A, Bradley E, Aldrete JS. Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg. 1989. 209:428–434.
15. Youn SM, Heo JS, Choi DW, et al. Comparative outcome after treatment for synchronous vs. Metachronous colorectal cancer liver metastasis. Korean J Hepatobiliary Pancreat Surg. 2010. 14:154–164.
16. Cady B, McDermott WV. Major hepatic resection for metachronous metastases from colon cancer. Ann Surg. 1985. 201:204–209.
17. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery. 1988. 103:278–288.
18. Ahn SW, Na AS, Yang JD, et al. Scoring of prognostic factors that influence long-term survival in patients with hepatic metastasis of colorectal cancer. Korean J Hepatobiliary Pancreat Surg. 2011. 15:146–151.
19. Cady B, Stone MD, McDermott WV Jr, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg. 1992. 127:561–568.
20. Oussoultzoglou E, Rosso E, Fuchshuber P, et al. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study. Arch Surg. 2008. 143:1150–1158.
21. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg. 1991. 214:107–113.
22. Doci R, Gennari L, Bignami P, et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg. 1991. 78:797–801.
23. Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998. 227:566–571.
Full Text Links
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr